STEPHEN DAVIS Insider Trading $BLCM BELLICUM PHARMACEUTICALS, INC
Get free email notifications about insider trading for STEPHEN DAVIS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STEPHEN DAVIS. STEPHEN DAVIS is Director in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and Exec. VP, Chief Oper. Officer in NEUROGEN CORP ($NRGN) and President in NEUROGEN CORP ($NRGN) and President, CEO in NEUROGEN CORP ($NRGN) and Sr VP, Chief Business Officer in NEUROGEN CORP ($NRGN) and Sr VP, Chief Operating Officer in NEUROGEN CORP ($NRGN) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and CEO in ACADIA PHARMACEUTICALS INC ($ACAD) and INTERIM CEO in ACADIA PHARMACEUTICALS INC ($ACAD) and PRESIDENT AND CEO in ACADIA PHARMACEUTICALS INC ($ACAD) and Director in BELLICUM PHARMACEUTICALS, INC ($BLCM).
STEPHEN DAVIS in BELLICUM PHARMACEUTICALS, INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEPHEN DAVIS: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 16 2020
$BLCM Market Capitalization: $335.83M
$BLCM Previous Close: $12.57
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of STEPHEN DAVIS in BELLICUM PHARMACEUTICALS, INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACAD, BLCM, HRTX, NRGN, GEVA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 16 2020 | BLCM | BELLICUM PHARMACEU ... | DAVIS STEPHEN | Director | Option Exercise | A | 8.42 | 6,500 | 54,730 | 6,500 | |
| Jun 16 2020 | BLCM | BELLICUM PHARMACEU ... | DAVIS STEPHEN | Director | Option Exercise | A | 8.42 | 6,500 | 54,730 | 6,500 | |
| Jun 14 2019 | BLCM | BELLICUM PHARMACEU ... | DAVIS STEPHEN | Director | Option Exercise | A | 1.96 | 25,000 | 49,000 | 25,000 | |
| Jun 18 2018 | BLCM | BELLICUM PHARMACEU ... | DAVIS STEPHEN | Director | Option Exercise | A | 9.80 | 10,000 | 98,000 | 10,000 | |
| Jun 15 2017 | BLCM | BELLICUM PHARMACEU ... | DAVIS STEPHEN | Director | Option Exercise | A | 10.34 | 10,000 | 103,400 | 10,000 | |
| Jun 15 2017 | BLCM | BELLICUM PHARMACEU ... | DAVIS STEPHEN | Director | Option Exercise | A | 10.34 | 10,000 | 103,400 | 10,000 | |
| Jun 17 2016 | BLCM | BELLICUM PHARMACEU ... | DAVIS STEPHEN | Director | Option Exercise | A | 12.44 | 10,000 | 124,400 | 10,000 | |
| Jul 15 2015 | BLCM | BELLICUM PHARMACEU ... | DAVIS STEPHEN | Director | Option Exercise | A | 20.25 | 9,167 | 185,632 | 9,167 | |
| Jul 15 2015 | BLCM | BELLICUM PHARMACEU ... | DAVIS STEPHEN | Director | Option Exercise | A | 20.25 | 20,000 | 405,000 | 20,000 |
Page: 1